Quotes for C100 AB
Right Now
- +/-
- %
- 0,00%
- Latest
- High
- Low
- Volume
- 0
- Turnover (SEK)
- 0
- Market Value (MSEK)
- 16,8
- Time (Latest trade)
Board
CEO
- Jacob Eriksson
Chairperson of the Board
- Oliver Aleksov
Board
- Alex Ghafori
- Daniel Rudeklint
- Per Karlsson
C100 is an investment company. The company is an owner and manager of a portfolio of growth companies around the global market, where the investment is mainly found in the technology and life science sectors. The vision is to create long-term returns and to drive business development within each investment. The company is headquartered in Stockholm.
News
- C100:s portföljbolag Hunter Capital RTO 1 ingår LOI med ResoTher Pharma - implicerad värdering om 365–405 MSEK
- C100 publicerar finansiell kalender för 2026
- C100 AB (publ) offentliggör bokslutskommuniké 2025
- C100 senarelägger bokslutskommunikén för 2025
- C100 senarelägger bokslutskommunikén för 2025
News agencies
- Finwire: C100 reports minor changes in results
- Finwire: C100 delays year-end report for 2025
- Finwire: C100 postpones the year-end report to 6 February
- Finwire: Hunter Capital sells shares in two reverse takeover companies to C100
- Finwire: Hunter Capital sells shares in subsidiaries to C100
Videos
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Futur Pension | 39,54 | 39,54 | 2026-03-27 |
| Hunter Capital AB | 18,74 | 18,74 | 2026-03-27 |
| Nowo Fund Management AB | 9,70 | 9,70 | 2026-03-27 |
| Scaninvest Ltd | 4,24 | 4,24 | 2026-03-27 |
| Johannes Schildt | 4,24 | 4,24 | 2026-03-27 |
| Oliver Aleksov | 1,80 | 1,80 | 2025-11-06 |
| Per Karlsson | 1,73 | 1,73 | 2025-06-26 |
| Vasa Capital AB | 1,39 | 1,39 | 2026-03-27 |
| Sandante Invest AB | 1,39 | 1,39 | 2026-03-27 |
| Nordnet Pensionsförsäkring | 1,38 | 1,38 | 2026-03-27 |
** Powered by Modular Finance
Insider trading
*Powered by Modular Finance
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2026-05-06 Interim Report 2026-Q1
-
2026-06-09 Annual General Meeting 2025
-
2026-08-31 Interim Report 2026-Q2
-
2026-11-30 Interim Report 2026-Q3